Home >> General Pharmaceuticals >> Housing >> Food & Beverage >>

Diabetic Foot Ulcers Global Clinical Trials Review, H1, 2014

Published: Apr-2014 | Format: PDF | GlobalData | Number of pages: 99 | Code: MRS - 24040


GlobalData's clinical trial report, "Diabetic Foot Ulcers Global Clinical Trials Review, H1, 2014" provides data on the Diabetic Foot Ulcers clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diabetic Foot Ulcers. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Diabetic Foot Ulcers. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Diabetic Foot Ulcers 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Diabetic Foot Ulcers to Metabolic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Diabetic Foot Ulcers to Metabolic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Diabetic Foot Ulcers 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Diabetic Foot Ulcers Therapeutics Clinical Trials 31
Prominent Drugs 33
Latest Clinical Trials News on Diabetic Foot Ulcers 34
Jan 16, 2014: Derma Sciences Provides Update on DSC127 Phase 3 Clinical Trials 34
Oct 10, 2013: Pergamum announces final data from Phase I/II study of LL-37 in patients with chronic leg ulcers 34
Aug 13, 2013: Grafix Demonstrates Overwhelming Efficacy in Landmark Stem Cell Study for the Treatment of Diabetic Foot Ulcers 35
Apr 25, 2013: Derma Sciences Begins Screening Patients In Second Phase III Trial With DSC127 For Healing Diabetic Foot Ulcers 36
Mar 18, 2013: Adocia Announces Phase III Development Program For Treatment Of Diabetic Foot Ulcer 37
Clinical Trial Profiles 38
Clinical Trial Overview of Top Companies 38
Smith & Nephew Plc 38
Clinical Trial Overview of Smith & Nephew Plc 38
Derma Sciences, Inc. 39
Clinical Trial Overview of Derma Sciences, Inc. 39
Pfizer Inc. 40
Clinical Trial Overview of Pfizer Inc. 40
CytoTools AG 41
Clinical Trial Overview of CytoTools AG 41
Johnson & Johnson 42
Clinical Trial Overview of Johnson & Johnson 42
Adocia 43
Clinical Trial Overview of Adocia 43
Kaken Pharmaceutical Co., Ltd. 44
Clinical Trial Overview of Kaken Pharmaceutical Co., Ltd. 44
Innocoll, Inc. 45
Clinical Trial Overview of Innocoll, Inc. 45
HealOr Ltd. (Inactive) 46
Clinical Trial Overview of HealOr Ltd. (Inactive) 46
Biotec Pharmacon ASA 47
Clinical Trial Overview of Biotec Pharmacon ASA 47
Clinical Trial Overview of Top Institutes / Government 48
Tehran University of Medical Sciences 48
Clinical Trial Overview of Tehran University of Medical Sciences 48
Karolinska Institutet 49
Clinical Trial Overview of Karolinska Institutet 49
Georgetown University 50
Clinical Trial Overview of Georgetown University 50
Ahvaz Jundishapur University of Medical Sciences 51
Clinical Trial Overview of Ahvaz Jundishapur University of Medical Sciences 51
Department of Health, South Africa 52
Clinical Trial Overview of Department of Health, South Africa 52
U.S. Department of Veterans Affairs 53
Clinical Trial Overview of U.S. Department of Veterans Affairs 53
University Hospital, Grenoble 54
Clinical Trial Overview of University Hospital, Grenoble 54
Chinese University of Hong Kong 55
Clinical Trial Overview of Chinese University of Hong Kong 55
Assaf-Harofeh Medical Center 56
Clinical Trial Overview of Assaf-Harofeh Medical Center 56
New York University School of Medicine 57
Clinical Trial Overview of New York University School of Medicine 57
Five Key Clinical Profiles 58
Appendix 97
Abbreviations 97
Definitions 97
Research Methodology 98
Secondary Research 98
About GlobalData 99
Contact Us 99
Disclaimer 99
Source 99

List of Tables

Diabetic Foot Ulcers Therapeutics, Global, Clinical Trials by Region, 2014* 7
Diabetic Foot Ulcers Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Diabetic Foot Ulcers Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Diabetic Foot Ulcers Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Diabetic Foot Ulcers Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Diabetic Foot Ulcers Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Diabetic Foot Ulcers Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Diabetic Foot Ulcers Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Diabetic Foot Ulcers to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 15
Diabetic Foot Ulcers Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Diabetic Foot Ulcers Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Diabetic Foot Ulcers to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 18
Diabetic Foot Ulcers Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Diabetic Foot Ulcers Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Diabetic Foot Ulcers Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Diabetic Foot Ulcers Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Diabetic Foot Ulcers Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Diabetic Foot Ulcers Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Diabetic Foot Ulcers Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Diabetic Foot Ulcers Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Diabetic Foot Ulcers Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Diabetic Foot Ulcers Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 29
Diabetic Foot Ulcers Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Diabetic Foot Ulcers Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 32
Diabetic Foot Ulcers Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 33
Diabetic Foot Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Smith & Nephew Plc, 2014* 38
Diabetic Foot Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Derma Sciences, Inc., 2014* 39
Diabetic Foot Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 40
Diabetic Foot Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by CytoTools AG, 2014* 41
Diabetic Foot Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014* 42
Diabetic Foot Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Adocia, 2014* 43
Diabetic Foot Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Kaken Pharmaceutical Co., Ltd., 2014* 44
Diabetic Foot Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Innocoll, Inc., 2014* 45
Diabetic Foot Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by HealOr Ltd. (Inactive), 2014* 46
Diabetic Foot Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Biotec Pharmacon ASA, 2014* 47
Diabetic Foot Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2014* 48
Diabetic Foot Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Karolinska Institutet, 2014* 49
Diabetic Foot Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Georgetown University, 2014* 50
Diabetic Foot Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Ahvaz Jundishapur University of Medical Sciences, 2014* 51
Diabetic Foot Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, South Africa, 2014* 52
Diabetic Foot Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014* 53
Diabetic Foot Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Grenoble, 2014* 54
Diabetic Foot Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2014* 55
Diabetic Foot Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Assaf-Harofeh Medical Center, 2014* 56
Diabetic Foot Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by New York University School of Medicine, 2014* 57

List of Figures

Diabetic Foot Ulcers Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Diabetic Foot Ulcers Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Diabetic Foot Ulcers Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Diabetic Foot Ulcers Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Diabetic Foot Ulcers Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Diabetic Foot Ulcers Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Diabetic Foot Ulcers Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Diabetic Foot Ulcers Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Diabetic Foot Ulcers to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 15
Diabetic Foot Ulcers Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Diabetic Foot Ulcers Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Diabetic Foot Ulcers to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 18
Diabetic Foot Ulcers Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Diabetic Foot Ulcers Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Diabetic Foot Ulcers Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Diabetic Foot Ulcers Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Diabetic Foot Ulcers Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Diabetic Foot Ulcers Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Diabetic Foot Ulcers Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Diabetic Foot Ulcers Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 29
Diabetic Foot Ulcers Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Diabetic Foot Ulcers Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Diabetic Foot Ulcers Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 33
GlobalData Methodology 98

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)2500 View Pricing